e-Drug3D

2119

M AZACITIDINE


INN
AZACITIDINE

(is an active metabolite)

cas 2226-74-6
CLASS

ANTINEOPLASTIC
ANTIMETABOLITES
FAB MYELODYSPLASTIC SYNDROME
CYTOTOXIC
NUCLEOSIDE ANALOG OF CYTIDINE
HYPOMETHYLATION OF DNA AND RNA AFTER PHOSPHORYLATION BY KINASE UCK2

ROUTE (list)

-

ATC code

L01BC07

PK parameters

Target

TARGET DNA
DNA (CYTOSINE-5)-METHYLTRANSFERASE 1 DNMT1

DrugCentral

DNA (cytosine-5)-methyltransferase 1 UNIPROT P26358 DNMT1

DNA (cytosine-5)-methyltransferase 3A UNIPROT Q9Y6K1 DNMT3A

Download SDF file 1,3,5-Triazin-2(1H)-one, 4-amino-1-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-beta-D-ribofuranosyl]- (9CI, ACI)

Formula:
C8H15N4O14P3

Calculated chemical properties:

MW 480.12
NB_atoms 29
XLogP -5.34
PSA 269.342
NB_HD 4
NB_HA 18
fsp3 0.62
Lipinski(0=no;1=yes) 0

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL